Tff Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $193 | $650 | $203 | $733 |
Gross Profit | 193 | 509 | 63 | 603 |
EBITDA | -3,582 | -3,962 | -5,594 | -5,238 |
EBIT | -4,103 | -5,735 | -5,368 | |
Net Income | -3,544 | -4,479 | -5,735 | -4,762 |
Net Change In Cash | 193 | 650 | 203 | 733 |
Free Cash Flow | -1,979 | -3,253 | -3,144 | -4,259 |
Cash | 2,606 | 4,387 | 3,211 | 5,478 |
Basic Shares | 4,372 | 3,667 | 2,387 | 2,365 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $733 | $0 | $ | $0 |
Gross Profit | 231 | -388 | -111 | |
EBITDA | -20,740 | -31,408 | -30,927 | -18,693 |
EBIT | -21,243 | -31,796 | -31,038 | -18,693 |
Net Income | -21,243 | -31,770 | -30,987 | -18,440 |
Net Change In Cash | 733 | 0 | 0 | |
Cost of Revenue | -1,540 | 7,276 | ||
Free Cash Flow | -16,132 | -28,893 | -30,425 | -17,718 |
Cash | 5,478 | 16,612 | 33,794 | 35,300 |
Basic Shares | 1,792 | 1,199 | 992 | 817 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.81 |
2024-06-30 | -$1.22 |
2024-03-31 | -$2.40 |
2023-12-31 | -$2.01 |
